查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863187

全球氧气疗法治疗设备市场：洞察、竞争格局及至2032年预测

Oxygen Therapy Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

氧气疗法设备市场摘要

  • 全球氧气疗法设备市场预计将从 2024 年的 32.9577 亿美元稳步增长到 2032 年的 58.6674 亿美元。
  • 全球氧气疗法设备市场预计在 2025 年至 2032 年的预测期内将以 7.52% 的复合年增长率成长。
  • 受呼吸系统疾病发病率上升、加护治疗应用范围扩大以及技术快速进步的推动，全球氧气疗法设备市场正经历强劲增长。慢性阻塞性肺病（COPD）、气喘和其他慢性肺部疾病发生率的不断攀升，推动了医院和居家医疗机构对持续氧气治疗的需求。在加护病房，氧气设备对于治疗严重呼吸系统或心臟併发症的患者至关重要。同时，人工智慧整合式製氧机、即时监测和携带式设计等创新技术，正在提高治疗的精准度和患者的便利性。这些因素共同推动了氧气疗法设备的广泛应用，并巩固了市场的成长势头。
  • 氧气疗法设备市场的主要企业包括 Koninklijke Philips NV、Invacare Corporation、Inogen, Inc.、Dragerwerk AG & Co. KgaA、ICU Medical, Inc.、CAIRE Inc.、Fisher & Paykel Healthcare Limited、Armstrong Medical、Vyaire MedicalBMC, Inc.、Hamilton Medical、深圳. Industries, Inc.、DeVilbiss Healthcare LLC、GCE Group、Oxygen Solutions Inc. 和 Besco Medical Limited。
  • 北美凭藉其完善的医疗保健基础设施、高发的慢性呼吸系统疾病和其他慢性疾病以及老龄化人口，在全球氧气疗法设备市场占据最大份额。该地区对携带式和固定式氧气浓缩机、人工智慧整合监测系统以及智慧氧气输送设备等医疗技术的先进应用，进一步巩固了其市场主导地位。家庭氧气疗法需求的不断增长，加上持续的技术创新和患者支援计划，正在加速氧气治疗设备的普及，并确保其持续成长。这些因素共同促成了北美在全球氧气疗法设备市场中主导且极具影响力的地位。
  • 在按产品类型分類的氧气疗法设备市场细分中，预计到 2024 年，系统导管类产品将占据最大的市场份额。

推动氧气疗法设备市场成长的因素

  • 呼吸系统疾病病例激增推动氧气疗法设备市场快速成长：慢性慢性阻塞性肺病肺病（COPD）、气喘、睡眠呼吸中止症和肺炎等慢性及急性呼吸系统疾病的日益普遍，是氧气疗法设备市场的主要驱动因素之一。世界卫生组织（WHO）指出，COPD仍然是全球导致发病率和死亡率的主要原因之一，尤其是在人口老化和空气污染严重的地区。呼吸衰竭和低氧血症患者数量的不断增长，显着推动了对氧气浓缩机、氧气瓶和便携式氧气设备的需求。此外，吸烟、职业性接触有毒气体以及都市区空气污染等生活方式因素也加剧了呼吸系统併发症的发生，促使临床和居家照护机构越来越多地采用氧气疗法。随着医疗保健系统将长期呼吸支持解决方案列为优先事项，疾病负担的不断加重将继续推动市场发展。
  • 这些设备在加护治疗中的关键应用：氧气疗法设备在加护治疗环境中发挥至关重要的作用，维持最佳氧气浓度对于患者的生存和康復至关重要。医院和加护病房(ICU) 越来越依赖先进的氧气输送系统来管理患有严重呼吸窘迫、术后併发症和心臟疾病的患者。呼吸衰竭、创伤和败血症急诊入院人数的增加进一步推动了对高性能固定式製氧机、人工呼吸器和氧气输送介面的需求。此外，监测技术和整合式氧气流量系统的进步使医护人员能够提供精确的氧浓度，有助于改善病患的治疗效果。随着加护治疗基础设施的不断完善和对先进呼吸支援的日益重视，氧气疗法设备在急性护理环境中的应用持续推动全球市场的发展。
  • 产品研发的快速创新：持续的技术进步正在改变氧气疗法设备的格局，提升便携性、效率和病患舒适度。现代氧气浓缩机采用紧凑型设计、长电池续航时间、自动流量调节和智慧连接功能，可实现远端监控和控制。人工智慧 (AI) 和物联网 (IoT) 技术的集成，能够即时追踪氧气使用情况和患者生命体征，从而优化治疗依从性和临床决策。此外，製造商还引入降噪系统、轻质材料和用户友好型介面，以改善患者体验，尤其是在居家医疗环境中。这些创新正在扩大氧气疗法的覆盖范围，使其不再局限于医院，并帮助患者独立管理慢性呼吸系统疾病。因此，产品的快速发展正在推动氧气疗法设备市场的广泛应用，并保持其长期成长动能。

《氧气疗法设备市场报告》全面概述了全球氧气疗法设备市场，重点分析了关键趋势、成长要素、挑战和机会。报告按产品类型、便携性、应用、最终用户和地区进行了详细的市场细分。报告深入分析了北美、欧洲和亚太地区等主要市场的竞争格局、法规环境和市场动态，并详细介绍了主要行业参与者和最新产品创新，为企业提供关键数据，以识别市场潜力、制定战略规划，并在快速增长的氧气疗法设备市场中把握新机会。

氧气疗法设备是为患有呼吸系统疾病或低氧血症的患者提供补充氧气的​​医疗设备。这些设备包括氧气浓缩机、氧气瓶、液态氧系统以及各种输送接口，例如面罩、氧气鼻管和人工呼吸器。它们广泛应用于医院、诊所和居家医疗机构，帮助慢性阻塞性肺病（COPD）、气喘和其他肺部疾病患者维持足够的氧饱和度并改善整体呼吸功能。

氧气疗法设备市场的成长主要受呼吸系统疾病发病率上升、加护治疗室（ICU）中氧疗设备使用量增加以及产品研发技术的快速创新所驱动。慢性呼吸系统疾病（如慢性阻塞性肺病、气喘和睡眠呼吸中止症）的日益普遍，加上空气污染和吸烟等环境因素，显着增加了医院和居家医疗机构对氧气疗法解决方案的需求。在加护治疗室中，氧气疗法设备在稳定呼吸窘迫、心臟併发症和术后患者方面发挥关键作用，促进了其在ICU和急诊的应用。同时，设备技术的快速发展，包括小型化、节能型和人工智慧整合型製氧机的研发，提高了治疗的准确性、患者的舒适度和移动性。即时氧气监测、自动流量调节和无线连接等功能使氧气疗法更加便捷易用，尤其适合长期居家使用。这些因素，加上技术进步以及临床和家庭对可靠呼吸支持解决方案日益增长的需求，共同推动了市场扩张。

由于临床、人口、环境和技术因素的共同作用，全球氧气疗法设备市场正在经历强劲且持续的增长，而气喘和慢性阻塞性肺病(COPD) 等慢性呼吸系统疾病的日益普遍是主要的成长要素。

根据DelveInsight的分析（2025年），全球有超过2.5亿人患有气喘，使其成为各年龄层中最常见的慢性疾病之一。同时，预计到2050年，慢性阻塞性肺病（COPD）患者人数将达到6亿人。空气污染加剧、烟草使用普遍、气候变迁、职业危害和快速都市化等环境因素进一步加剧了呼吸系统疾病的快速增长。此外，老年人口的不断增长，使得老年人患慢性病和反覆住院的风险更高，从而增加了医院、加护病房、门诊机构和居家医疗机构对氧气疗法设备的需求。

在加护治疗环境中，对持续氧疗的需求不断增长，尤其是那些患有严重呼吸窘迫、心臟併发症和术后併发症的患者，需要可靠的氧气供应，这进一步推动了市场对氧气支持的需求。同时，科技的快速发展正在改变这个产业。携带式和固定式氧气浓缩机、人工智慧整合监测系统、智慧输氧设备以及用户友好型介面等创新技术，提高了治疗的精准度，改善了患者的舒适度，并促进了治疗依从性。此外，携带式和连网设备在居家照护解决方案中的日益普及，也为长期呼吸系统疾病患者提供了更多便利。

支持性的法规结构、对早期诊断和适当介入的日益重视，以及不断加强的病患教育，正进一步加速氧气疗法设备的普及应用。这些因素共同凸显了氧气疗法解决方案在现代医疗保健中的关键作用，并为市场的持续成长奠定了基础。疾病盛行率的上升、技术的创新、人口结构的变化以及医疗实践的演进，正共同推动着呼吸治疗向以患者为中心的先进模式转变，从而改善临床疗效，提高生活质量，并满足全球医疗保健系统日益增长的需求。

儘管氧气疗法设备市场具有巨大的成长潜力，但仍面临许多阻碍其扩张的重大挑战。其中一个主要阻碍因素是政府部门实施的严格监管准则，这往往导致新产品核准流程漫长而复杂。虽然这些法规对于确保病患安全和设备有效性至关重要，但它们也延长了产品上市时间，并增加了额外的财务负担，尤其对中小企业新兴企业更是如此。

此外，氧气疗法高成本，主要原因是氧气机设备复杂、维护要求高，以及某些地区报销力度有限，这些因素进一步限制了氧气治疗的普及，尤其是在中低收入国家。这些因素共同构成了市场渗透的巨大障碍，迫使製造商专注于成本效益高的创新和合规策略，以在监管日益严格、成本意识日益增强的环境中维持成长。

氧气疗法设备市场細項分析氧气疗法设备市场按产品类型、便携性、应用、最终用户和地区进行细分。

北美将引领全球氧气疗法设备市场，预计到2024年将占据约42%的市场。北美氧气疗法设备市场的扩张受多种关键因素所驱动，其中最重要的是慢性呼吸系统疾病盛行率的上升。根据DelveInsight的分析（2024年），美国有超过3,550万人患有慢性肺部疾病，包括气喘和慢性阻塞性肺病（COPD）。其中，约有1,150万成年人（占美国成年人口的4.6%）被诊断出患有COPD，包括慢性支气管炎和肺气肿。

这些进行性性呼吸系统疾病会损害肺功能，对患者、看护者和医疗保健系统造成沉重负担。慢性阻塞性肺病（COPD）和气喘率的上升直接推动了对先进氧气疗法解决方案的需求。慢性呼吸系统疾病患者通常需要长期吸氧，而对可靠的家用氧气疗法、携带式製氧机和智慧氧气输送设备的需求不断增长，正在重塑市场趋势。

氧气疗法设备的创新，例如整合人工智慧的製氧机、即时监测系统和携带式穿戴设备，正在提高患者的安全性、依从性和治疗效果。这些解决方案能够持续监测血氧水平、自动调节氧气流量并实现远端连接，确保患者获得持续有效的治疗，同时减轻医护人员的负担。

疾病流行率的上升，以及对呼吸系统研究和患者支持投入的不断增加，正在塑造市场动态。诸如美国肺臟协会等组织持续加大研究经费投入，并推动旨在提高公众对肺部疾病的认识、促进早期诊断和改善疾病管理的各项项目。这些努力透过教育病患、看护者和医护人员如何正确使用、监测和坚持治疗，来促进先进氧气疗法设备的普及应用。

因此，疾病高发生率、居家医疗的日益普及、技术创新、研究经费的增加以及患者支持计划的扩大，预计将推动美国氧气疗法设备市场在 2025 年至 2032 年的预测期内持续增长。

欧洲氧气疗法设备市场的成长主要受癌症和心血管疾病等慢性病盛行率上升的推动，这些疾病需要透过氧气疗法设备反覆输注药物和液体。化疗数量的增加以及儿科患者对氧疗设备使用量的增加，也促进了市场扩张。

氧气疗法设备的科技进步，例如抗菌涂层导管和嵌入式感测器技术，提高了患者安全性，并减少了感染疾病和血栓症等併发症。这些创新，加上欧洲各地不断增加的研究活动和临床试验，正在加速先进设备的应用。目前，短週边静脉导管在收入方面占据市场主导，但由于中线导管具有临床优势并能改善患者预后，因此它是成长最快的产品类别。

从区域来看，英国、德国、法国、西班牙和义大利等国家引领市场，其中英国预计将占据最大份额，这得益于其先进的医疗基础设施和在研发方面的大量投入。医疗设备法规 (MDR) 的合规性以及新型治疗方法的引入也在影响市场动态。此外，居家输液治疗和微创手术的显着普及进一步推动了对先进血管通路和氧气疗法解决方案的需求。整体而言，欧洲市场呈现出需求稳定成长、技术持续创新以及医疗实践不断发展的平衡态势。

亚太地区氧气疗法设备市场预计将在2025年至2032年间以9.27%的强劲复合年增长率成长。这个市场快速扩张的原因在于慢性阻塞性肺病（COPD）、气喘和其他肺部疾病等慢性呼吸系统疾病的盛行率不断上升，从而增加了对氧气疗法解决方案的需求。此外，该地区庞大且老化的人口也促进了市场成长，因为老年人更有可能需要长期氧气疗法。印度、中国和日本等国家是主要市场，其中印度预计将实现最高的成长率。

儘管目前固定式和携带式氧气浓缩器仍占据市场主导地位，但携带式和可穿戴式製氧机因其便利性和对居家照护的适应性而增长最快。医疗基础设施的持续发展、政府旨在改善医疗设备可近性的倡议以及不断增长的医疗费用支出也推动了市场扩张。多家区域性和全球性公司正积极投资研发和新产品推出，以推动技术创新并提高设备效率。

此外，患者友善、微创氧气输送系统的日益普及，以及智慧监测和人工智慧功能的不断融合，正在推动市场成长。因此，亚太地区凭藉着不断扩大的患者群体、日益完善的医疗基础设施以及氧气疗法设备的持续创新，成为全球成长最快的市场。

以下是氧气疗法设备市场的主要企业，它们合计占据最大的市场份额，并主导产业趋势：

  • Koninklijke Philips NV
  • Invacare Corporation
  • Inogen, Inc.
  • Dragerwerk AG & Co. KgaA
  • ICU Medical, Inc.
  • CAIRE Inc.
  • Fisher & Paykel Healthcare Limited
  • Armstrong Medical
  • Vyaire Medical, Inc.
  • Hamilton Medical
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • BMC Medical Co., Ltd.
  • Allied Medical Limited
  • Teleflex Incorporated
  • HERSILL
  • Chart Industries, Inc.
  • DeVilbiss Healthcare LLC
  • GCE Group
  • Oxygen Solutions Inc.
  • Besco Medical Limited

氧气疗法设备市场的竞争格局呈现出成熟全球企业与新兴创新者并存的局面。该市场高度集中，飞利浦伟康 (Philips Respironics)、Inogen、CAIRE、林德医疗 (Linde Healthcare) 和瑞思迈 (ResMed) 等主要企业占据着显着的市场份额，尤其是在高科技固定式和携带式氧气浓缩机、液氧系统和先进的输氧接口领域。这些领导企业凭藉持续的研发投入、强大的品牌知名度和多元化的产品系列保持着竞争优势，其产品组合能够满足包括医院、居家照护和长期护理机构在内的各种呼吸护理需求。

同时，一些规模小、反应敏捷的公司和Start-Ups正透过推出创新解决方案和智慧氧气疗法技术来重塑市场格局。许多新晋参与企业正在推动新兴领域的成长，例如人工智慧驱动的监测系统、携带式和可穿戴式製氧机，以及旨在实现更互联、更人性化的患者设备。透过实现即时监测、自动氧气输送调节和远端系统管理，这些企业正在帮助患者从以医院为基础的治疗模式转向更灵活的家庭和门诊呼吸照护模式。

现有企业与创新新进者之间的这种互动，孕育了一个以技术快速进步和策略联盟为特征的竞争环境。领先企业积极寻求合作、收购和技术整合，以提高设备效率、拓展产品系列併维持市场领先地位。因此，竞争不仅推动了创新和患者疗效的提升，也加速了便利、高效且以患者为中心的氧气疗法方案在全球的普及。

氧气疗法设备市场最新发展动态

  • 2025 年 6 月，专注于居家医疗先进呼吸解决方案的领先医疗技术公司 Inogen, Inc. 宣布推出 Voxi™ 5，这是一款新型固定式氧气浓缩器(SOC)，旨在改善美国长期护理患者获得高品质氧气疗法的机会。这款新产品丰富了 Inogen 的产品线，完善了其携带式氧气浓缩机产品组合，扩大了市场机会，并充分利用了其已建立的分销和销售管道。
  • 2025 年 6 月，全球呼吸照护公司 VARON 正式推出专为墨西哥市场设计的新平台，以应对该国慢性呼吸系统疾病数量的增长，使得提供可靠的家庭氧气疗法成为医疗优先事项。
  • 2025 年 1 月，Caire 宣布推出其新型固定式氧气浓缩器IntenOxy 5。该公司表示，该产品目前已在美国和波多黎各上市，并计划在不久的将来将销售范围扩大到加拿大。

氧气疗法设备市场细分

  • 按产品类型分類的氧气疗法设备趋势
  • 系统
  • 高流量氧气鼻管氧气疗法（HFNO）装置
  • 氧气浓缩机
  • 人工呼吸器
  • 其他的
  • 一次性用品和配件
  • 氧气罩
  • 氧气鼻管
  • 人工呼吸袋
  • 其他的
  • 按便携性分類的氧气疗法设备发展趋势
  • 固定式
  • 便携的
  • 氧气疗法设备的用途和使用环境
  • 慢性阻塞性肺病
  • 气喘
  • 呼吸窘迫症候群
  • 其他的
  • 氧气疗法设备终端用户趋势
  • 医院和诊所
  • 门诊手术中心
  • 居家医疗环境
  • 其他的
  • 氧气疗法设备的区域趋势
  • 北美氧气疗法设备市场
  • 美国氧气疗法设备市场
  • 加拿大氧气疗法设备市场
  • 墨西哥氧气疗法设备市场
  • 欧洲氧气疗法设备市场
  • 英国氧气疗法设备市场
  • 德国氧气疗法设备市场
  • 法国氧气疗法设备市场
  • 义大利氧气疗法设备市场
  • 西班牙氧气疗法设备市场
  • 其他欧洲氧气疗法设备市场
  • 亚太地区氧气疗法设备市场
  • 中国氧气疗法设备市场
  • 日本氧气疗法设备市场
  • 印度氧气疗法设备市场
  • 澳洲氧气疗法设备市场
  • 韩国氧气疗法设备市场
  • 亚太地区其他氧气疗法设备市场
  • 世界其他地区氧气疗法设备市场
  • 南美洲氧气疗法设备市场
  • 中东氧气疗法设备市场
  • 非洲氧气疗法设备市场

影响分析：人工智慧的创新与应用：

人工智慧正透过提供更智慧、更个人化、更有效率的呼吸照护解决方案，迅速改变氧气疗法设备市场。人工智慧驱动的氧气浓缩机和输送系统可以即时监测患者的血氧饱和度，分析其变化趋势，并自动调节流量以维持最佳血氧水平。这些智慧系统能够改善治疗效果，并降低高氧血症和低氧血症的风险，这对于慢性呼吸系统疾病患者尤其重要。

除了自动调节流量外，人工智慧整合还支援远端监控和预测性维护，使医护人员能够追踪患者依从性、检测异常情况并在设备故障发生前进行预测。机器学习演算法还能分析多名患者的大型资料集，以识别治疗模式、优化治疗通讯协定并辅助临床决策。此外，人工智慧解决方案透过提供语音控制、行动应用整合以及低电量或氧气供应中断的即时警报，提升了携带式氧气设备的便利性。透过这些方式，人工智慧创新正在改善患者安全、治疗效果以及家庭和临床环境中氧气疗法的可近性。

美国关税对氧气疗法设备市场的影响分析：

美国对进口医疗设备和原料加征关税，对氧气疗法设备市场产生了复杂的影响。虽然关税的整体意图是鼓励国内生产，减少对外国供应链的依赖，但也给整个价值链带来了成本压力。许多氧气浓缩机、气瓶、阀门、压缩机、感测器和其他组件都来自国际供应商，或由这些供应商组装，尤其是在中国、德国和日本。对这些进口组件征收关税可能会增加美国製造商的生产成本，进而导致终端用户价格上涨，并增加医疗机构和居家病患的负担。

新冠疫情期间，美国曾暂时降低部分医疗设备的关税，以防止氧气供应中断。但由于贸易摩擦持续不断，长期关税结构仍不明朗。製造商正采取措施抵消不断上涨的进口关税，例如供应链多元化、生产在地化以及投资自动化。然而，中小企业应对这些额外成本的能力有限，利润率面临压力。

另一方面，关税也起到了促进国内创新和推动氧气疗法设备关键製造流程（尤其是过滤器和感测器等关键零件）回流的作用。因此，儘管关税会透过增加製造成本和物流成本带来短期挑战，但从长远来看，它可能有助于增强美国氧气疗法设备市场的韧性和技术独立性。

目录

第一章氧气疗法设备市场报告概述

  • 调查范围
  • 市场区隔
  • 市场假设

第二章氧气疗法设备市场执行摘要

  • 市场概览

第三章氧气疗法设备市场关键因素分析

  • 市场驱动因素
    • 呼吸系统疾病增加
    • 这些设备在加护治疗中的重要用途
    • 产品开发中的快速创新
  • 市场限制与挑战
    • 严格的政府监管准则延缓了产品核准。
    • 医疗成本不断上涨
  • 市场机会
    • 新兴市场尚未开发的潜力
    • 提高人们对氧气疗法的认识

第四章 影响分析

  • 人工智慧驱动的创新和应用
  • 美国关税的影响分析

第五章 监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第六章氧气疗法设备市场：波特五力分析

第七章氧气疗法设备市场评估

  • 依产品类型
    • 系统
    • 一次性产品及配件
  • 透过便携性
    • 固定式
    • 可携式的
  • 透过使用
    • COPD
    • 气喘
    • 呼吸窘迫症候群
    • 其他的
  • 最终用户
    • 医院和诊所
    • 门诊手术中心
    • 居家照护
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

第十章氧气疗法设备市场公司及产品概况

  • Koninklijke Philips NV
  • Invacare Corporation
  • Inogen, Inc.
  • Dragerwerk AG & Co. KgaA
  • ICU Medical, Inc.
  • CAIRE Inc.
  • Fisher & Paykel Healthcare Limited
  • Armstrong Medical
  • Vyaire Medical, Inc.
  • Hamilton Medical
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • BMC Medical Co., Ltd.
  • Allied Medical Limited
  • Teleflex Incorporated
  • HERSILL
  • Chart Industries, Inc.
  • DeVilbiss Healthcare LLC
  • GCE Group
  • Oxygen Solutions Inc.
  • Besco Medical Limited

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0478

Oxygen Therapy Equipment Market Summary

  • The global oxygen therapy equipment market is expected to increase from USD 3,295.77 million in 2024 to USD 5,866.74 million by 2032, reflecting strong and sustained growth.
  • The global oxygen therapy equipment market is growing at a CAGR of 7.52% during the forecast period from 2025 to 2032.
  • The global oxygen therapy equipment market is witnessing robust growth driven by the rising prevalence of respiratory diseases, expanding use in critical care, and rapid technological advancements. Increasing cases of COPD, asthma, and other chronic lung conditions have heightened the demand for continuous oxygen support in both hospitals and home care settings. In critical care units, oxygen devices are indispensable for managing patients with severe respiratory or cardiac complications. Simultaneously, innovations such as AI-integrated concentrators, real-time monitoring, and portable designs are improving treatment precision and patient convenience. Together, these factors are fueling widespread adoption and strengthening the market's growth trajectory.
  • The leading companies operating in the oxygen therapy equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Dragerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited, and others.
  • North America holds the highest share in the global oxygen therapy equipment market, driven by a well-established healthcare infrastructure, a high prevalence of chronic respiratory and other chronic diseases, and a growing aging population. The region's advanced adoption of medical technologies, including portable and stationary oxygen concentrators, AI-integrated monitoring systems, and smart oxygen delivery devices, further reinforces its market dominance. Rising demand for home-based oxygen therapy, coupled with continuous technological innovation and supportive patient programs, is accelerating adoption and ensuring sustained growth. These factors collectively position North America as a leading and highly influential market in the global oxygen therapy equipment landscape.
  • Within the product type segment of the oxygen therapy equipment market, the system catheters category is projected to hold the largest share in 2024.

Factors Contributing to the Growth of the Oxygen Therapy Equipment Market

  • Increase in the Cases of Respiratory Disorders Leading to Surge in the Oxygen Therapy Equipment Market: The increasing prevalence of chronic and acute respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and pneumonia, is one of the primary drivers of the oxygen therapy equipment market. According to the World Health Organization (WHO), COPD remains a leading cause of morbidity and mortality worldwide, particularly in aging populations and regions with high air pollution levels. The growing number of patients suffering from respiratory insufficiency and hypoxemia has significantly elevated the demand for oxygen concentrators, cylinders, and portable oxygen devices. Moreover, lifestyle factors such as smoking, occupational exposure to harmful gases, and urban pollution are contributing to rising respiratory complications, leading to higher oxygen therapy adoption in both clinical and home care settings. This surge in disease burden continues to propel the market forward as healthcare systems prioritize long-term respiratory support solutions.
  • Significant Usage of These Devices in Critical Care: Oxygen therapy equipment plays a vital role in critical care environments, where maintaining optimal oxygen levels is essential for survival and recovery. Hospitals and intensive care units (ICUs) increasingly rely on advanced oxygen delivery systems for managing patients with severe respiratory distress, postoperative complications, and cardiac conditions. The growing incidence of emergency admissions due to respiratory failure, trauma, or sepsis further drives demand for high-performance stationary concentrators, ventilators, and oxygen delivery interfaces. Additionally, advancements in monitoring technologies and integrated oxygen flow systems enable clinicians to deliver precise oxygen concentrations, improving patient outcomes. With the expansion of critical care infrastructure and a growing emphasis on advanced respiratory support, the use of oxygen therapy equipment in acute settings continues to strengthen the market globally.
  • Rapid Technical Innovation in Product Development: Continuous technological innovation is transforming the oxygen therapy equipment landscape by improving portability, efficiency, and patient comfort. Modern oxygen concentrators now feature compact designs, longer battery life, automated flow adjustment, and smart connectivity that allows remote monitoring and control. The integration of artificial intelligence (AI) and Internet of Things (IoT) technologies enables real-time tracking of oxygen usage and patient vitals, optimizing treatment adherence and clinical decision-making. Furthermore, manufacturers are introducing noise-reduction systems, lightweight materials, and user-friendly interfaces to enhance patient experience, particularly in home care settings. These innovations are expanding accessibility to oxygen therapy beyond hospitals, empowering patients to manage chronic respiratory conditions independently. As a result, rapid product advancements are driving wider adoption and sustaining the long-term growth trajectory of the oxygen therapy equipment market.

Oxygen Therapy Equipment Market Report Segmentation

This oxygen therapy equipment market report offers a comprehensive overview of the global oxygen therapy equipment market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation By Product Type (Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, and Others] and Disposables and Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, and Others]), Portability (Stationary and Portable), Application (COPD, Asthma, Respiratory Distress Syndrome, and Others), End-Users (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing Oxygen Therapy Equipment market.

The oxygen therapy equipment refers to medical devices designed to deliver supplemental oxygen to individuals with respiratory disorders or conditions that cause low blood oxygen levels. These devices include oxygen concentrators, cylinders, liquid oxygen systems, and delivery interfaces such as masks, nasal cannulas, and ventilators. They are used across hospitals, clinics, and home care settings to support patients with chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary conditions, helping maintain adequate oxygen saturation and improve overall respiratory function.

The growth of the oxygen therapy equipment market is being strongly driven by the rising incidence of respiratory conditions, the increasing use of these devices in critical care, and rapid technological innovations in product development. The growing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, coupled with environmental factors like air pollution and smoking, has significantly increased the demand for oxygen therapy solutions across both hospital and home care settings. In critical care environments, oxygen therapy equipment plays a vital role in stabilizing patients suffering from respiratory distress, cardiac complications, and postoperative conditions, driving adoption in ICUs and emergency departments. Meanwhile, rapid advancements in device technology, including the development of compact, energy-efficient, and AI-integrated concentrators, are enhancing treatment accuracy, patient comfort, and mobility. Features such as real-time oxygen monitoring, automated flow adjustment, and wireless connectivity are making oxygen therapy more accessible and user-friendly, especially for long-term home use. Collectively, these factors are reinforcing the market's expansion by aligning technological progress with the growing clinical and home-based demand for reliable respiratory support solutions.

What are the latest Oxygen Therapy Equipment Market Dynamics and Trends?

The global oxygen therapy equipment market is witnessing strong and sustained growth, driven by a combination of clinical, demographic, environmental, and technological factors. The rising prevalence of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) represents a major growth driver.

According to DelveInsight analysis (2025), over 250 million people globally are living with asthma, making it one of the most widespread chronic conditions across all age groups, while COPD cases are projected to reach 600 million by 2050. Environmental factors, including escalating air pollution, widespread tobacco use, climate change, occupational hazards, and rapid urbanization, have further contributed to the surge in respiratory ailments. In parallel, the expanding geriatric population, which is more vulnerable to chronic illnesses and repeated hospitalizations, is creating additional demand for oxygen therapy equipment across hospitals, critical care units, outpatient facilities, and home care settings.

The growing need for continuous oxygen support in critical care environments, where patients with severe respiratory distress, cardiac complications, or post-surgical conditions require reliable oxygen delivery, is further driving market adoption. At the same time, rapid technological advancements are transforming the sector. Innovations such as portable and stationary oxygen concentrators, AI-integrated monitoring systems, smart delivery devices, and user-friendly interfaces are enhancing treatment precision, improving patient comfort, and promoting adherence to therapy. The increasing focus on home-based care solutions, enabled by portable and connected devices, is also expanding access and convenience for patients managing long-term respiratory conditions.

Supportive regulatory frameworks, growing awareness about early diagnosis and timely intervention, and initiatives to improve patient education are further accelerating the adoption of oxygen therapy equipment. Collectively, these factors underscore the critical role of oxygen therapy solutions in modern healthcare, positioning the market for sustained growth. The convergence of rising disease prevalence, technological innovation, demographic shifts, and evolving care practices is driving a transformative shift toward advanced, patient-centric respiratory therapies that enhance clinical outcomes, improve quality of life, and meet the increasing demands of healthcare systems worldwide.

Despite strong growth potential, the oxygen therapy equipment market faces several key challenges that hinder its expansion. One major restraint is the presence of strict regulatory guidelines imposed by government authorities, which often result in lengthy and complex approval processes for new products. These regulations, while essential for ensuring patient safety and device efficacy, increase the time-to-market and impose additional financial burdens on manufacturers, particularly smaller or emerging companies.

In addition, the high cost of oxygen therapy, driven by advanced concentrators, maintenance requirements, and limited reimbursement support in certain regions, further restricts accessibility, especially in low- and middle-income countries. Together, these factors create significant barriers to market penetration, compelling manufacturers to focus on cost-effective innovations and compliance strategies to sustain growth in an increasingly regulated and cost-sensitive environment.

Oxygen Therapy Equipment Market Segment Analysis

Oxygen Therapy Equipment Market by Product Type (Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, and Others] and Disposables and Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, and Others]), Portability (Stationary and Portable), Application (COPD, Asthma, Respiratory Distress Syndrome, and Others), End-Users (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Oxygen Therapy Equipment Market Regional Analysis

North America Oxygen Therapy Equipment Market Trends

North America, led by the United States, dominates the global oxygen therapy equipment market, accounting for approximately 42% of the total market share in 2024. The expansion of the North America oxygen therapy equipment market is being driven by several critical factors, foremost among them the rising prevalence of chronic respiratory diseases. According to the DelveInsight analysis (2024), more than 35.5 million people in the U.S. live with chronic lung conditions, including asthma and chronic obstructive pulmonary disease (COPD). Within this population, approximately 11.5 million adults, representing 4.6% of the U.S. adult population, have been diagnosed with COPD, encompassing chronic bronchitis and emphysema.

These progressive respiratory conditions impair pulmonary function and place a substantial burden on patients, caregivers, and the healthcare system. The rising incidence of COPD and asthma is directly accelerating demand for advanced oxygen therapy solutions. Patients with chronic respiratory conditions often require long-term supplemental oxygen, and the increasing need for reliable home-based oxygen therapy, portable concentrators, and smart oxygen delivery devices is reshaping market demand.

Technological innovations in oxygen therapy equipment, such as AI-integrated concentrators, real-time monitoring systems, and portable wearable devices, are enhancing patient safety, adherence, and treatment efficacy. These solutions enable continuous monitoring of blood oxygen levels, automated oxygen flow adjustments, and remote connectivity, ensuring patients receive consistent and effective therapy while reducing healthcare burdens.

In addition to disease prevalence, increased investment in respiratory research and patient support is shaping market dynamics. Organizations such as the American Lung Association continue to expand research funding and programs to improve awareness, early diagnosis, and management of lung diseases. These initiatives support the adoption of advanced oxygen therapy devices by educating patients, caregivers, and healthcare providers on proper usage, monitoring, and adherence.

Therefore, the combination of high disease prevalence, growing home healthcare adoption, technological innovation, increased research funding, and supportive patient programs is expected to drive sustained growth in the U.S. oxygen therapy equipment market over the forecast period from 2025 to 2032.

Europe Oxygen Therapy Equipment Market Trends

The growth of the European oxygen therapy equipment market is driven primarily by the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, which necessitate repeated administration of medications and fluids through oxygen therapy devices. The increasing number of chemotherapy treatments, along with the growing utilization of these devices in pediatric patients, further contributes to market expansion.

Technological advancements in oxygen therapy equipment, including antimicrobial-coated catheters and sensor-enabled technologies, are improving patient safety and reducing complications such as infections and thrombosis. These innovations, combined with increased research activities and clinical trials across Europe, are accelerating the adoption of advanced devices. Currently, short peripheral intravenous catheters dominate the market in terms of revenue, while midline catheters represent the fastest-growing product segment due to their clinical advantages and improved patient outcomes.

Geographically, countries such as the United Kingdom, Germany, France, Spain, and Italy lead the market, with the UK expected to hold the largest share thanks to its advanced healthcare infrastructure and substantial investments in research and development. Regulatory compliance with the EU Medical Device Regulation (MDR) and the adoption of novel therapeutic approaches are also shaping market dynamics. Additionally, a noticeable shift toward home-infusion therapies and minimally invasive procedures is driving further demand for advanced vascular access and oxygen therapy solutions. Overall, the market reflects a balance of steady demand growth, continuous technological innovation, and evolving healthcare practices across Europe.

Asia-Pacific Oxygen Therapy Equipment Market Trends

The Asia-Pacific oxygen therapy equipment market is experiencing strong growth momentum, projected to register a 9.27% CAGR from 2025 to 2032. The market is expanding rapidly due to the rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary disorders, which increase the demand for oxygen therapy solutions. The region's large and aging population further contributes to market growth, as older adults are more likely to require long-term oxygen therapy. Countries such as India, China, and Japan are key markets, with India expected to register the highest growth rate.

Stationary and portable oxygen concentrators currently dominate the product segment, while portable and wearable devices are the fastest-growing due to their convenience and suitability for home-based care. Market expansion is also supported by ongoing healthcare infrastructure development, government initiatives to improve access to medical devices, and rising healthcare expenditure. Several regional and global players are actively investing in research and new product launches, driving technological advancements and improving device efficiency.

Additionally, increasing adoption of patient-friendly, minimally invasive oxygen delivery systems and the integration of smart monitoring and AI-powered features are shaping the market's upward trajectory. Thus, the Asia-Pacific region stands out as the fastest-growing market globally, driven by expanding patient populations, enhanced healthcare infrastructure, and continuous innovation in oxygen therapy equipment.

Who are the major players in the Oxygen Therapy Equipment Market?

The following are the leading companies in the oxygen therapy equipment market. These companies collectively hold the largest market share and dictate industry trends.

  • Koninklijke Philips N.V.
  • Invacare Corporation
  • Inogen, Inc.
  • Dragerwerk AG & Co. KgaA
  • ICU Medical, Inc.
  • CAIRE Inc.
  • Fisher & Paykel Healthcare Limited
  • Armstrong Medical
  • Vyaire Medical, Inc.
  • Hamilton Medical
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • BMC Medical Co., Ltd.
  • Allied Medical Limited
  • Teleflex Incorporated
  • HERSILL
  • Chart Industries, Inc.
  • DeVilbiss Healthcare LLC
  • GCE Group
  • Oxygen Solutions Inc.
  • Besco Medical Limited

How is the competitive landscape shaping the Oxygen Therapy Equipment Market?

The competitive landscape of the oxygen therapy equipment market reflects a balance between established global corporations and emerging innovators. The market is highly consolidated, with major players such as Philips Respironics, Inogen, CAIRE Inc., Linde Healthcare, and ResMed holding significant market share, particularly in high-tech stationary and portable oxygen concentrators, liquid oxygen systems, and advanced delivery interfaces. These leaders maintain their dominance through continuous research and development, strong brand recognition, and diversified product portfolios that cater to a wide range of respiratory care needs across hospitals, home care, and long-term care settings.

At the same time, smaller, agile companies and startups are reshaping the market by introducing innovative solutions and smart oxygen therapy technologies. Many of these new entrants are driving growth in emerging segments, including AI-powered monitoring systems, portable and wearable concentrators, and devices with enhanced connectivity and patient-friendly designs. By enabling real-time monitoring, automated oxygen delivery adjustments, and remote management, they are supporting a shift from hospital-centric care to more flexible, home-based, and outpatient respiratory care.

This interplay between established incumbents and innovative disruptors is fostering a competitive environment characterized by rapid technological advancement and strategic collaborations. Larger corporations are increasingly engaging in partnerships, acquisitions, and technology integrations to enhance device efficiency, expand product portfolios, and maintain market leadership. As a result, competition is driving not only innovation and improved patient outcomes but also accelerating the adoption of more convenient, efficient, and patient-centric oxygen therapy solutions worldwide.

Recent Developmental Activities in the Oxygen Therapy Equipment Market

  • In June 2025, Inogen, Inc., a prominent medical technology company focused on advanced respiratory solutions for home care, unveiled the Voxi(TM) 5, a new stationary oxygen concentrator (SOC) aimed at improving access to high-quality oxygen therapy for long-term care patients in the United States. This latest addition to Inogen's product lineup complements its range of portable oxygen concentrators, broadening market opportunities and capitalizing on the company's established distribution and sales channels.
  • In June 2025, VARON, a global respiratory care company, officially introduced a new platform specifically designed for the Mexican market, responding to the growing healthcare priority of providing reliable home oxygen therapy amid rising chronic respiratory conditions in the country.
  • In January 2025, Caire announced the launch of its new IntenOxy 5 stationary oxygen concentrator. According to the company, the device is now available for purchase in the United States and Puerto Rico, with plans to expand availability to Canada in the near future.

Oxygen Therapy Equipment Market Segmentation

  • Oxygen Therapy Equipment Product Type Exposure
  • Systems
  • HFNO (High-Flow Nasal Cannula Oxygenation) Devices
  • Oxygen Concentrators
  • Ventilators
  • Others
  • Disposables and Accessories
  • Oxygen Masks
  • Nasal Cannulas
  • Resuscitator Bags
  • Others
  • Oxygen Therapy Equipment Portability Exposure
  • Stationary
  • Portable
  • Oxygen Therapy Equipment Application Exposure
  • COPD
  • Asthma
  • Respiratory Distress Syndrome
  • Others
  • Oxygen Therapy Equipment End-Users Exposure
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others
  • Oxygen Therapy Equipment Geography Exposure
  • North America Oxygen Therapy Equipments Market
  • United States Oxygen Therapy Equipments Market
  • Canada Oxygen Therapy Equipments Market
  • Mexico Oxygen Therapy Equipments Market
  • Europe Oxygen Therapy Equipments Market
  • United Kingdom Oxygen Therapy Equipments Market
  • Germany Oxygen Therapy Equipments Market
  • France Oxygen Therapy Equipments Market
  • Italy Oxygen Therapy Equipments Market
  • Spain Oxygen Therapy Equipments Market
  • Rest of Europe Oxygen Therapy Equipments Market
  • Asia-Pacific Oxygen Therapy Equipments Market
  • China Oxygen Therapy Equipments Market
  • Japan Oxygen Therapy Equipments Market
  • India Oxygen Therapy Equipments Market
  • Australia Oxygen Therapy Equipments Market
  • South Korea Oxygen Therapy Equipments Market
  • Rest of Asia-Pacific Oxygen Therapy Equipments Market
  • Rest of the World Oxygen Therapy Equipments Market
  • South America Oxygen Therapy Equipments Market
  • Middle East Oxygen Therapy Equipments Market
  • Africa Oxygen Therapy Equipments Market

Impact Analysis

AI-Powered Innovations and Applications:

Artificial intelligence is rapidly transforming the oxygen therapy equipment market by enabling smarter, more personalized, and efficient respiratory care solutions. AI-powered oxygen concentrators and delivery systems can monitor a patient's oxygen saturation in real time, analyze trends, and automatically adjust flow rates to maintain optimal blood oxygen levels. These intelligent systems improve therapeutic outcomes and reduce the risk of over- or under-oxygenation, which is particularly critical for patients with chronic respiratory conditions.

Beyond automated flow regulation, AI integration facilitates remote monitoring and predictive maintenance, allowing healthcare providers to track patient compliance, detect anomalies, and anticipate device malfunctions before they occur. Machine learning algorithms can also analyze large datasets from multiple patients to identify patterns, optimize treatment protocols, and support clinical decision-making. Additionally, AI-driven solutions are enhancing the usability of portable oxygen devices, providing voice-assisted controls, mobile app connectivity, and real-time alerts for low battery or depleted oxygen supply. Thus, AI innovations are improving patient safety, treatment effectiveness, and the accessibility of oxygen therapy in both home and clinical settings.

U.S. Tariff Impact Analysis on the Oxygen Therapy Equipment Market:

The imposition of U.S. tariffs on imported medical devices and raw materials has had a mixed impact on the oxygen therapy equipment market. While the broader intent of tariffs is to encourage domestic manufacturing and reduce reliance on foreign supply chains, they have also led to cost pressures across the value chain. Many oxygen concentrators, cylinders, and parts such as valves, compressors, and sensors are sourced or assembled from international suppliers, particularly in China, Germany, and Japan. Tariffs on these imported components have increased production costs for U.S.-based manufacturers, resulting in higher end-user prices and potentially limiting affordability for healthcare providers and home care patients.

During the COVID-19 pandemic, the United States temporarily eased certain medical device tariffs to ensure an uninterrupted oxygen supply, but as trade tensions continue, the long-term tariff structure remains uncertain. Manufacturers have responded by diversifying supply chains, localizing production, and investing in automation to offset higher import duties. However, smaller and mid-sized companies face tighter profit margins due to limited capacity to absorb these added costs.

On the positive side, tariffs have encouraged domestic innovation and the reshoring of key oxygen therapy device manufacturing, particularly in critical components like filters and sensors. Therefore, while tariffs create short-term challenges through increased manufacturing and logistics costs, they may support long-term resilience and technological self-reliance within the U.S. oxygen therapy equipment market.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Oxygen Therapy Equipment market report study

  • Market size analysis for the current oxygen therapy equipment market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the oxygen therapy equipment market.
  • Various opportunities available for the other competitors in the oxygen therapy equipment market.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current oxygen therapy equipment market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the oxygen therapy equipment market growth in the future?

Frequently Asked Questions for the Oxygen Therapy Equipment Market

1. What is the growth rate of the oxygen therapy equipment market?

  • The oxygen therapy equipment market is estimated to grow at a CAGR of 7.52% during the forecast period from 2025 to 2032.

2. What is the market for oxygen therapy equipment?

  • The oxygen therapy equipment market was valued at USD 3,295.77 million in 2024 and is expected to reach USD 5,866.74 million by 2032.

3. Which region has the highest share in the oxygen therapy equipment market?

  • North America holds the highest share in the global oxygen therapy equipment market, driven by a well-established healthcare infrastructure, a high prevalence of chronic respiratory and other chronic diseases, and a growing aging population. The region's advanced adoption of medical technologies, including portable and stationary oxygen concentrators, AI-integrated monitoring systems, and smart oxygen delivery devices, further reinforces its market dominance. Rising demand for home-based oxygen therapy, coupled with continuous technological innovation and supportive patient programs, is accelerating adoption and ensuring sustained growth. These factors collectively position North America as a leading and highly influential market in the global oxygen therapy equipment landscape.

4. What are the drivers for the oxygen therapy equipment market?

  • The global oxygen therapy equipment market is witnessing robust growth driven by the rising prevalence of respiratory diseases, expanding use in critical care, and rapid technological advancements. Increasing cases of COPD, asthma, and other chronic lung conditions have heightened the demand for continuous oxygen support in both hospitals and home care settings. In critical care units, oxygen devices are indispensable for managing patients with severe respiratory or cardiac complications. Simultaneously, innovations such as AI-integrated concentrators, real-time monitoring, and portable designs are improving treatment precision and patient convenience. Together, these factors are fueling widespread adoption and strengthening the market's growth trajectory.

5. Who are the key players operating in the oxygen therapy equipment market?

  • Some of the key market players operating in the oxygen therapy equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Dragerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited, and Others.

Table of Contents

1. Oxygen Therapy Equipment Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Oxygen Therapy Equipment Market Executive Summary

  • 2.1 Market at Glance

3. Oxygen Therapy Equipment Market Key Factors Analysis

  • 3.1 Oxygen Therapy Equipment Market Drivers
    • 3.1.1 Increase in the cases of respiratory disorders
    • 3.1.2 Significant usage of these devices in critical care
    • 3.1.3 Rapid technical innovation in product development
  • 3.2 Oxygen Therapy Equipment Market Restraints and Challenges
    • 3.2.1 Strict regulatory guidelines by the government are causing delays in product approvals
    • 3.2.2 The high cost of therapy
  • 3.3 Oxygen Therapy Equipment Market Opportunity
    • 3.3.1 Untapped potential of emerging markets
    • 3.3.2 Increasing awareness regarding oxygen therapy

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Oxygen Therapy Equipment Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Oxygen Therapy Equipment Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Systems
      • 7.1.1.1 HFNO (High-Flow Nasal Cannula Oxygenation) Devices
      • 7.1.1.2 Oxygen Concentrators
      • 7.1.1.3 Ventilators
      • 7.1.1.4 Others
    • 7.1.2 Disposables and Accessories
      • 7.1.2.1 Oxygen Masks
      • 7.1.2.2 Nasal Cannulas
      • 7.1.2.3 Resuscitator Bags
      • 7.1.2.4 Others
  • 7.2 By Portability
    • 7.2.1 Stationary
    • 7.2.2 Portable
  • 7.3 By Applications
    • 7.3.1 COPD
    • 7.3.2 Asthma
    • 7.3.3 Respiratory Distress Syndrome
    • 7.3.4 Others
  • 7.4 By End-Users
    • 7.4.1 Hospitals and Clinics
    • 7.4.2 Ambulatory Surgical Centers
    • 7.4.3 Home Care Settings
    • 7.4.4 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.1.2 Canada Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.1.3 Mexico Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.2 Europe
      • 7.5.2.1 France Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.2 Germany Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.3 United Kingdom Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.4 Italy Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.5 Spain Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.6 Rest of Europe Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.2 Japan Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.3 India Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.4 Australia Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.5 South Korea Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.6 Rest of Asia-Pacific Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 Middle East Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.4.2 Africa Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.4.3 South America Oxygen Therapy Equipment Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Oxygen Therapy Equipment Market Company and Product Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Invacare Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Inogen, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Dragerwerk AG & Co. KgaA
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 ICU Medical, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 CAIRE Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Fisher & Paykel Healthcare Limited
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Armstrong Medical
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Vyaire Medical, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Hamilton Medical
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Shenzhen Comen Medical Instruments Co., Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 BMC Medical Co., Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Allied Medical Limited
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Teleflex Incorporated
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 HERSILL
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Chart Industries, Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 DeVilbiss Healthcare LLC
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 GCE Group
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Oxygen Solutions Inc.
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Besco Medical Limited
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Oxygen Therapy Equipment Market in Global (2022-2032)
  • Table 2: Oxygen Therapy Equipment Market in Global by Product Type (2022-2032)
  • Table 3: Oxygen Therapy Equipment Market in Global by Portability (2022-2032)
  • Table 4: Oxygen Therapy Equipment Market in Global by Application (2022-2032)
  • Table 5: Oxygen Therapy Equipment Market in Global by End-Users (2022-2032)
  • Table 6: Oxygen Therapy Equipment Market in Global by Geography (2022-2032)
  • Table 7: Oxygen Therapy Equipment Market in North America (2022-2032)
  • Table 8: Oxygen Therapy Equipment Market in the United States (2022-2032)
  • Table 9: Oxygen Therapy Equipment Market in Canada (2022-2032)
  • Table 10: Oxygen Therapy Equipment Market in Mexico (2022-2032)
  • Table 11: Oxygen Therapy Equipment Market in Europe (2022-2032)
  • Table 12: Oxygen Therapy Equipment Market in France (2022-2032)
  • Table 13: Oxygen Therapy Equipment Market in Germany (2022-2032)
  • Table 14: Oxygen Therapy Equipment Market in United Kingdom (2022-2032)
  • Table 15: Oxygen Therapy Equipment Market in Italy (2022-2032)
  • Table 16: Oxygen Therapy Equipment Market in Spain (2022-2032)
  • Table 17: Oxygen Therapy Equipment Market in the Rest of Europe (2022-2032)
  • Table 18: Oxygen Therapy Equipment Market in Asia-Pacific (2022-2032)
  • Table 19: Oxygen Therapy Equipment Market in China (2022-2032)
  • Table 20: Oxygen Therapy Equipment Market in Japan (2022-2032)
  • Table 21: Oxygen Therapy Equipment Market in India (2022-2032)
  • Table 22: Oxygen Therapy Equipment Market in Australia (2022-2032)
  • Table 23: Oxygen Therapy Equipment Market in South Korea (2022-2032)
  • Table 24: Oxygen Therapy Equipment Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Oxygen Therapy Equipment Market in the Rest of the World (2022-2032)
  • Table 26: Oxygen Therapy Equipment Market in the Middle East (2022-2032)
  • Table 27: Oxygen Therapy Equipment Market in Africa (2022-2032)
  • Table 28: Oxygen Therapy Equipment Market in South America (2022-2032)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Oxygen Therapy Equipment Market Drivers
  • Figure 2: Oxygen Therapy Equipment Market Restraints
  • Figure 3: Oxygen Therapy Equipment Market Opportunities
  • Figure 4: AI-Powered Innovations in the Oxygen Therapy Equipment Market
  • Figure 5: US Tariff Impact on Oxygen Therapy Equipment Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Oxygen Therapy Equipment Market in Global (2022-2032)
  • Figure 10: Oxygen Therapy Equipment Market in Global by Product Type (2022-2032)
  • Figure 11: Oxygen Therapy Equipment Market in Global by Portability (2022-2032)
  • Figure 12: Oxygen Therapy Equipment Market in Global by Application (2022-2032)
  • Figure 13: Oxygen Therapy Equipment Market in Global by End-Users (2022-2032)
  • Figure 14: Oxygen Therapy Equipment Market in Global by Geography (2022-2032)
  • Figure 15: Oxygen Therapy Equipment Market in North America (2022-2032)
  • Figure 16: Oxygen Therapy Equipment Market in the United States (2022-2032)
  • Figure 17: Oxygen Therapy Equipment Market in Canada (2022-2032)
  • Figure 18: Oxygen Therapy Equipment Market in Mexico (2022-2032)
  • Figure 19: Oxygen Therapy Equipment Market in Europe (2022-2032)
  • Figure 20: Oxygen Therapy Equipment Market in France (2022-2032)
  • Figure 21: Oxygen Therapy Equipment Market in Germany (2022-2032)
  • Figure 22: Oxygen Therapy Equipment Market in United Kingdom (2022-2032)
  • Figure 23: Oxygen Therapy Equipment Market in Italy (2022-2032)
  • Figure 24: Oxygen Therapy Equipment Market in Spain (2022-2032)
  • Figure 25: Oxygen Therapy Equipment Market in the Rest of Europe (2022-2032)
  • Figure 26: Oxygen Therapy Equipment Market in Asia-Pacific (2022-2032)
  • Figure 27: Oxygen Therapy Equipment Market in China (2022-2032)
  • Figure 28: Oxygen Therapy Equipment Market in Japan (2022-2032)
  • Figure 29: Oxygen Therapy Equipment Market in India (2022-2032)
  • Figure 30: Oxygen Therapy Equipment Market in Australia (2022-2032)
  • Figure 31: Oxygen Therapy Equipment Market in South Korea (2022-2032)
  • Figure 32: Oxygen Therapy Equipment Market in Rest of Asia-Pacific (2022-2032)
  • Figure 33: Oxygen Therapy Equipment Market in the Rest of the World (2022-2032)
  • Figure 34: Oxygen Therapy Equipment Market in the Middle East (2022-2032)
  • Figure 35: Oxygen Therapy Equipment Market in Africa (2022-2032)
  • Figure 36: Oxygen Therapy Equipment Market in South America (2022-2032)
  • Figure 37: Competitive Landscape
  • Figure 38: Startup Funding & Investment Trends